Trends in quality of care among children with sickle cell anemia
dc.contributor.author | Reeves, Sarah L. | |
dc.contributor.author | Freed, Gary L. | |
dc.contributor.author | Madden, Brian | |
dc.contributor.author | Wu, Meng | |
dc.contributor.author | Miller, Lauren | |
dc.contributor.author | Cogan, Lindsay | |
dc.contributor.author | Anders, David | |
dc.contributor.author | Creary, Susan E. | |
dc.contributor.author | McCormick, Julie | |
dc.contributor.author | Dombkowski, Kevin J. | |
dc.date.accessioned | 2022-01-06T15:48:43Z | |
dc.date.available | 2023-03-06 10:48:42 | en |
dc.date.available | 2022-01-06T15:48:43Z | |
dc.date.issued | 2022-02 | |
dc.identifier.citation | Reeves, Sarah L.; Freed, Gary L.; Madden, Brian; Wu, Meng; Miller, Lauren; Cogan, Lindsay; Anders, David; Creary, Susan E.; McCormick, Julie; Dombkowski, Kevin J. (2022). "Trends in quality of care among children with sickle cell anemia." Pediatric Blood & Cancer 69(2): n/a-n/a. | |
dc.identifier.issn | 1545-5009 | |
dc.identifier.issn | 1545-5017 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/171152 | |
dc.description.abstract | IntroductionFor decades, it has been recommended that children with sickle cell anemia (SCA) receive antibiotic prophylaxis to prevent serious infections and undergo transcranial Doppler (TCD) screening to identify those at highest risk of overt stroke. We assessed recent temporal trends in antibiotic prophylaxis prescription fills and TCD screening among children with SCA using validated quality measures.ProcedureUsing validated claims‐based definitions, we identified children with SCA who were enrolled in Michigan or New York State (NYS) Medicaid programs (2011–2018). Among recommended age groups, two outcomes were assessed yearly: (a) filling of ≥300 days of antibiotics, and (b) receipt of greater than or equal to one TCD. The proportion of children with each outcome was calculated by state. Temporal trends in each preventive service were assessed using generalized linear models.ResultsA total of 1784 children were eligible for antibiotic prophylaxis (Michigan: 384; NYS: 1400), contributing 3322 person‐years. Annual rates of filling ≥300 days of antibiotics ranged from 16% to 22% and were similar by state. There was no change in rates of antibiotic filling over time in Michigan (p‐value: .10), but there was a decrease in NYS (p‐value: .02). A total of 3439 children with SCA were eligible for TCD screening (Michigan: 710; NYS: 2729), contributing 10,012 person‐years. Annual rates of TCD screening ranged from 39% to 45%, were similar by state, and did not change over time (p‐values >.05).ConclusionsMost children with SCA do not receive recommended antibiotic prophylaxis and/or TCD screening. New, sustainable, and coordinated interventions across preventive services are urgently needed. | |
dc.publisher | National Quality Forum (NQF) | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | epidemiology | |
dc.subject.other | sickle cell anemia | |
dc.subject.other | quality of life | |
dc.title | Trends in quality of care among children with sickle cell anemia | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Pediatrics | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/171152/1/pbc29446.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/171152/2/pbc29446_am.pdf | |
dc.identifier.doi | 10.1002/pbc.29446 | |
dc.identifier.source | Pediatric Blood & Cancer | |
dc.identifier.citedreference | Smith D, Bach J, Lyon‐Callo S, Young W. A public health strategic plan to address sickle cell disease across the lifespan. Michigan Department of Health and Human Services. Updated October 2015. Accessed April 30, 2020. https://www.michigan.gov/documents/mdhhs/MDHHS_Final_SCD_Strategic_Plan_504325_7.pdf | |
dc.identifier.citedreference | Reeves S, Garcia E, Kleyn M, et al. Identifying sickle cell disease cases using administrative claims. Acad Pediatr. 2014; 14 ( 5 Suppl): S61 ‐ S67. | |
dc.identifier.citedreference | Reeves SL, Madden B, Wu M, et al. Performance of ICD‐10‐CM diagnosis codes for identifying children with sickle cell anemia. Health Serv Res. 2020; 55 ( 2 ): 310 ‐ 317. | |
dc.identifier.citedreference | Health Services Advisory Group. 2019 HEDIS Aggregate Report for Michigan Medicaid. Michigan Department of Health and Human Services. Updated September 2019. Accessed January 18, 2021. https://www.michigan.gov/documents/mdhhs/MI2019_HEDIS‐Aggregate_Report_rev_669299_7.pdf | |
dc.identifier.citedreference | Sox CM, Cooper WO, Koepsell TD, DiGiuseppe DL, Christakis DA. Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA. 2003; 290 ( 8 ): 1057 ‐ 1061. | |
dc.identifier.citedreference | Eckrich MJ, Wang WC, Yang E, et al. Adherence to transcranial Doppler screening guidelines among children with sickle cell disease. Pediatr Blood Cancer. 2013; 60 ( 2 ): 270 ‐ 274. | |
dc.identifier.citedreference | Bundy DG, Abrams MT, Strouse JJ, Mueller CH, Miller MR, Casella JF. Transcranial Doppler screening of Medicaid‐insured children with sickle cell disease. J Pediatr. 2015; 166 ( 1 ): 188 ‐ 190. | |
dc.identifier.citedreference | Kwiatkowski JL, Voeks JH, Kanter J, et al. Ischemic stroke in children and young adults with sickle cell disease in the post‐STOP era. Am J Hematol. 2019; 94 ( 12 ): 1335 ‐ 1343. | |
dc.identifier.citedreference | Armstrong‐Wells J, Grimes B, Sidney S, et al. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology. 2009; 72 ( 15 ): 1316 ‐ 1321. | |
dc.identifier.citedreference | Reeves S, Madden B, Shevrin C, McCormick J, Freed G, Dombkowski K. Transcranial Doppler screening among children with sickle cell anemia. National Quality Forum (NQF). Accessed October 22, 2019. https://chear.org/sites/default/files/TranscranialDopplerScreeningMeasureSpecification.pdf | |
dc.identifier.citedreference | Weisman JK, Diamond CE, Kappa S, Nickel RS. Transcranial Doppler screening adherence among children with sickle cell anemia seen in the emergency department. J Pediatr. 2020; 217: 172 ‐ 176.e1. | |
dc.identifier.citedreference | Lewen MO, Kavanagh PL, Sobota AE. A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia. Am J Hematol. 2017; 92 ( 6 ): E121 ‐ E122. | |
dc.identifier.citedreference | Bollinger LM, Nire KG, Rhodes MM, Chisolm DJ, O’Brien SH. Caregivers’ perspectives on barriers to transcranial Doppler screening in children with sickle‐cell disease. Pediatr Blood Cancer. 2011; 56 ( 1 ): 99 ‐ 102. | |
dc.identifier.citedreference | Shook LM, Farrell CB, Kalinyak KA, et al. Translating sickle cell guidelines into practice for primary care providers with Project ECHO. Med Educ Online. 2016; 21: 33616. | |
dc.identifier.citedreference | Meier ER, Janson IA, Hampton K, et al. Adherence to quality of care indicators and location of sickle cell care within Indiana. J Community Health. 2020; 45 ( 1 ): 81 ‐ 87. | |
dc.identifier.citedreference | Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol. J Manag Care Spec Pharm. 2014; 20 ( 8 ): 851 ‐ 861. | |
dc.identifier.citedreference | McCarville MB, Goodin GS, Fortner G, et al. Evaluation of a comprehensive transcranial Doppler screening program for children with sickle cell anemia. Pediatr Blood Cancer. 2008; 50 ( 4 ): 818 ‐ 821. | |
dc.identifier.citedreference | Freed GL. A missed opportunity to address a national shame: the case of sickle cell disease in the United States. JAMA Pediatr. 2019; 173 ( 8 ): 715 ‐ 716. | |
dc.identifier.citedreference | Kanter J, Smith WR, Desai PC, et al. Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects. Blood Adv. 2020; 4 ( 16 ): 3804 ‐ 3813. | |
dc.identifier.citedreference | Lloyd R. Standardize before you improve. Institute for Healthcare Improvement. July 3, 2018. Accessed December 20, 2018. http://www.ihi.org/communities/blogs/standardize‐before‐you‐improve | |
dc.identifier.citedreference | Soltani M, Batt R, Bavafa H. Quality improvement spillovers: evidence from the hospital readmissions reduction program. Posted 2018. Accessed December 5, 2019. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3132770 | |
dc.identifier.citedreference | Yue D, Pourat N, Chen X, et al. Enabling services improve access to care, preventive services, and satisfaction among health center patients. Health Aff (Millwood). 2019; 38 ( 9 ): 1468 ‐ 1474. | |
dc.identifier.citedreference | Galvin SL, Grandy R, Woodall T, Parlier AB, Thach S, Landis SE. Improved utilization of preventive services among patients following team‐based annual wellness visits. N C Med J. 2017; 78 ( 5 ): 287 ‐ 295. | |
dc.identifier.citedreference | Garcia‐Huidobro D, Shippee N, Joseph‐DiCaprio J, O’Brien JM, Svetaz MV. Effect of patient‐centered medical home on preventive services for adolescents and young adults. Pediatrics. 2016; 137 ( 6 ): e20153813. | |
dc.identifier.citedreference | Powers BJ, Olsen MK, Oddone EZ, Bosworth HB. The effect of a hypertension self‐management intervention on diabetes and cholesterol control. Am J Med. 2009; 122 ( 7 ): 639 ‐ 646. | |
dc.identifier.citedreference | Ibrahim AM, Nathan H, Thumma JR, Dimick JB. Impact of the hospital readmission reduction program on surgical readmissions among medicare beneficiaries. Ann Surg. 2017; 266 ( 4 ): 617 ‐ 624. | |
dc.identifier.citedreference | Adams RJ, McKie VC, Carl EM, et al. Long‐term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997; 42 ( 5 ): 699 ‐ 704. | |
dc.identifier.citedreference | Ashorobi D, Bhatt R. Bone Marrow Transplantation in Sickle Cell Disease. StatPearls Publishing; 2020. | |
dc.identifier.citedreference | Agrawal N, Johnston SC, Wu YW, Sidney S, Fullerton HJ. Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke. 2009; 40 ( 11 ): 3415 ‐ 3421. | |
dc.identifier.citedreference | Sickle cell disease. National Heart Lung and Blood Institute. Accessed February 22, 2018. https://www.nhlbi.nih.gov/health/health‐topics/topics/sca | |
dc.identifier.citedreference | Stuart MJ, Nagel RL. Sickle‐cell disease. Lancet. 2004; 364 ( 9442 ): 1343 ‐ 1360. | |
dc.identifier.citedreference | Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008; 359 ( 21 ): 2254 ‐ 2265. | |
dc.identifier.citedreference | Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009; 114 ( 25 ): 5117 ‐ 5125. | |
dc.identifier.citedreference | Ohene‐Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998; 91 ( 1 ): 288 ‐ 294. | |
dc.identifier.citedreference | Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986; 314 ( 25 ): 1593 ‐ 1599. | |
dc.identifier.citedreference | Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998; 19 ( 1 ): 110 ‐ 129. | |
dc.identifier.citedreference | Cherry M, Greenhalgh J, Osipenko L, et al. The clinical effectiveness and cost‐effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation. Health Technol Access. 2012; 16 ( 43 ): 1 ‐ 129. https://doi.org/10.3310/hta16430 | |
dc.identifier.citedreference | Sickle cell disease: milestones and clinical progress. National Heart Lung and Blood Institute. Revised 2018. Accessed November 8, 2021. https://www.nhlbi.nih.gov/sites/default/files/publications/Sickle_Cell_Milestones_in_Research_508_Updated_0.pdf | |
dc.identifier.citedreference | The management of sickle cell disease. National Heart Lung and Blood Institute. Revised 2002. Accessed February 22, 2019. https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf | |
dc.identifier.citedreference | Evidence‐based management of sickle cell disease: expert panel report, 2014. National Heart Lung and Blood Institute. Accessed May 8, 2020. https://www.nhlbi.nih.gov/sites/default/files/media/docs/sickle‐cell‐disease‐report%20020816_0.pdf | |
dc.identifier.citedreference | Transcranial Doppler Ultrasonography Screening for Children with Sickle Cell Disease. National Quality Forum (NQF). Accessed November 8, 2021. http://www.qualityforum.org/QPS/2797. Transcranial Doppler Ultrasonography Screening for Children with Sickle Cell Disease. | |
dc.identifier.citedreference | Antibiotic prophylaxis among children with sickle cell anemia. National Quality Forum (NQF). Accessed October 22, 2019. http://www.qualityforum.org/QPS/3166. | |
dc.identifier.citedreference | Measure evaluation criteria. National Quality Forum (NQF). Accessed January 19, 2020. http://www.qualityforum.org/Measuring_Performance/Submitting_Standards/Measure_Evaluation_Criteria.aspx | |
dc.identifier.citedreference | Reeves SL, Madden B, Freed GL, Dombkowski KJ. Transcranial Doppler screening among children and adolescents with sickle cell anemia. JAMA Pediatr. 2016; 170 ( 6 ): 550 ‐ 556. | |
dc.identifier.citedreference | Reeves SL, Tribble AC, Madden B, Freed GL, Dombkowski KJ. Antibiotic prophylaxis for children with sickle cell anemia. Pediatrics. 2018; 141 ( 3 ): e20172182. | |
dc.identifier.citedreference | Reeves SL, Jary HK, Gondhi JP, Kleyn M, Wagner AL, Dombkowski KJ. Pneumococcal vaccination coverage among children with sickle cell anemia, sickle cell trait, and normal hemoglobin. Pediatr Blood Cancer. 2018; 65 ( 10 ): e27282. | |
dc.identifier.citedreference | Library of Congress. S.2465 ‐ Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018. Library of Congress. Accessed November 19, 2019. https://www.congress.gov/bill/115th‐congress/senate‐bill/2465 | |
dc.identifier.citedreference | Agency for Healthcare Research and Quality (AHRQ). P ediatric Quality Measures Program (PQMP). AHRQ. Accessed January 19, 2020. https://www.ahrq.gov/pqmp/index.html | |
dc.identifier.citedreference | U.S. Department of Health and Human Services, Office of Minority Health. About Sickle Cell Disease. U.S. Department of Health and Human Services, OMH. Accessed November 19, 2019. https://www.minorityhealth.hhs.gov/sicklecell/index.html | |
dc.identifier.citedreference | Centers for Medicare & Medicaid Services. CMS Health Equity Blog ‐ On the Path to Health Equity: Improving the Quality of Sickle Cell Disease Care. Centers for Medicare & Medicaid Services. Accessed November 19, 2019. https://www.cms.gov/About‐CMS/Agency‐Information/OMH/about‐cms‐omh/blog/sickle‐cell‐disease‐care.html | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.